ALLMedicine™ Aceruloplasminemia Center
Research & Reviews 35 results
https://doi.org/10.1080/08880018.2022.2140235
Pediatric Hematology and Oncology; Gok V, Ozcan A et. al.
Oct 30th, 2022 - Aceruloplasminemia inherited autosomal recessively in the ceruloplasmin gene is a progressive disease with iron accumulation in various organs such as the brain, liver, pancreas, and retina. Ceruloplasmin gene encodes ceruloplasmin protein, which ...
https://clinicaltrials.gov/ct2/show/NCT04184453
Nov 23rd, 2021 - Diabetes is one of the most severe symptom in aceruloplasminemia. In this study, we use R2* of pancreas MRI to evaluate the effect of deferiprone treatment.
https://doi.org/10.21037/apm-21-1086
Annals of Palliative Medicine; Xiao Y, Zhu C et. al.
Oct 22nd, 2021 - Hereditary aceruloplasminemia (ACP) is a rare adult-onset autosomal recessive disease characterized by a ceruloplasmin (CP) gene mutation and defective or absent CP function. In the present study, we report a case of ACP in a 34-year-old Chinese w...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293166
Magnetic Resonance in Medicine; Bossoni L, Hegeman-Kleinn I et. al.
Oct 17th, 2021 - To employ an off-resonance saturation method to measure the mineral-iron pool in the postmortem brain, which is an endogenous contrast agent that can give information on cellular iron status. An off-resonance saturation acquisition protocol was im...
https://doi.org/10.1007/s11011-021-00799-0
Metabolic Brain Disease; Xu WQ, Ni W et. al.
Aug 5th, 2021 - Aceruloplasminemia (ACP) is a rare disorder of iron overload resulting from ceruloplasmin (CP) variants. Because of its rarity and heterogeneity, the diagnosis of ACP is often missed or misdiagnosed. Here, we aim to present a clinical spectrum of ...
Clinicaltrials.gov 1 results
https://clinicaltrials.gov/ct2/show/NCT04184453
Nov 23rd, 2021 - Diabetes is one of the most severe symptom in aceruloplasminemia. In this study, we use R2* of pancreas MRI to evaluate the effect of deferiprone treatment.
